A third elbow procedure on Detroit pitcher Tarik Skubal throws the 2026‑27 free‑agency market into doubt. Six months of industry polling had pegged a 7.7‑year, $357 million deal—an average annual value that would eclipse Max Scherzer’s record. The latest surgery, removing loose bodies, forces agents to temper expectations.

Labor talks loom, with teams eager to lock in big‑money signings before the December 1 deadline. A potential lockout could see clubs like the New York Mets and Philadelphia Phillies swoon early, but durability concerns may keep Skubal’s price tag lower. Meanwhile, the posting market shrinks; Korean and Japanese clubs face a tighter 45‑day window that could push fringe players toward NPB.

Position‑player options remain murky. Jazz Chisholm Jr. and Freddy Peralta lead the charge, while outfielders from Daulton Varsho to George Springer vie for short‑term deals. The Mets, carrying a $71 million payroll hit, may re‑sign veterans and target depth, whereas the Cubs confront a larger payroll puzzle as they aim to shore up a rotation that has lost three‑fifths of its starters.

The season’s trajectory hinges on Skubal’s recovery and whether a lockout forces teams to act before the CBA expires.